Evidence map›Paper›PMID 27101845›Full record

ArticleDisease models & mechanisms2016

Musculocontractural Ehlers-Danlos syndrome and neurocristopathies: dermatan sulfate is required for Xenopus neural crest cells to migrate and adhere to fibronectin.

Nadège Gouignard, Marco Maccarana, Ina Strate, Kristoffer von Stedingk, Anders Malmström, Edgar M Pera

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. TheFrontiers in medicine · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Dermatan sulfate epimerase 1 and dermatan 4-The Journal of biological chemistry · 2018
    Article
  12. Article
  13. A genome wide association study of fast beta EEG in families of European ancestry.International journal of psychophysiology : official journal of the International Organization of Psychophysiology · 2017
    Article
  14. Modeling human craniofacial disorders inCurrent pathobiology reports · 2017
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nadège GouignardDepartment of Laboratory Medicine, Lund Stem Cell Center, Lund University, Lund 221 84, Sweden.
Marco MaccaranaDepartment of Experimental Medical Science, Lund University, Lund 221 84, Sweden.
Ina StrateDepartment of Laboratory Medicine, Lund Stem Cell Center, Lund University, Lund 221 84, Sweden.
Kristoffer von StedingkDepartment of Pediatrics, Lund University, Lund 223 63, Sweden.
Anders MalmströmDepartment of Experimental Medical Science, Lund University, Lund 221 84, Sweden.
Edgar M PeraDepartment of Laboratory Medicine, Lund Stem Cell Center, Lund University, Lund 221 84, Sweden edgar.pera@med.lu.se.ORCID 0000-0002-0625-0006
Lund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Of all live births with congenital anomalies, approximately one-third exhibit deformities of the head and face. Most craniofacial disorders are associated with defects in a migratory stem and progenitor cell population, which is designated the neural crest (NC). Musculocontractural Ehlers-Danlos syndrome (MCEDS) is a heritable connective tissue disorder with distinct craniofacial features; this syndrome comprises multiple congenital malformations that are caused by dysfunction of dermatan sulfate (DS) biosynthetic enzymes, including DS epimerase-1 (DS-epi1; also known as DSE). Studies in mice have extended our understanding of DS-epi1 in connective tissue maintenance; however, its role in fetal development is not understood. We demonstrate that DS-epi1 is important for the generation of isolated iduronic acid residues in chondroitin sulfate (CS)/DS proteoglycans in early Xenopus embryos. The knockdown of DS-epi1 does not affect the formation of early NC progenitors; however, it impairs the correct activation of transcription factors involved in the epithelial-mesenchymal transition (EMT) and reduces the extent of NC cell migration, which leads to a decrease in NC-derived craniofacial skeleton, melanocytes and dorsal fin structures. Transplantation experiments demonstrate a tissue-autonomous role for DS-epi1 in cranial NC cell migration in vivo Cranial NC explant and single-cell cultures indicate a requirement of DS-epi1 in cell adhesion, spreading and extension of polarized cell processes on fibronectin. Thus, our work indicates a functional link between DS and NC cell migration. We conclude that NC defects in the EMT and cell migration might account for the craniofacial anomalies and other congenital malformations in MCEDS, which might facilitate the diagnosis and development of therapies for this distressing condition. Moreover, the presented correlations between human DS-epi1 expression and gene sets of mesenchymal character, invasion and metastasis in neuroblastoma and malignant melanoma suggest an association between DS and NC-derived cancers.

Indexed as

AnimalsBase SequenceBiomarkersCell AdhesionCell MovementCell PolarityChondroitin SulfatesDermatan SulfateEhlers-Danlos SyndromeEmbryo, NonmammalianFeedback, PhysiologicalFibronectinsGene Expression Regulation, DevelopmentalIduronic AcidModels, BiologicalMusclesBiomarkersChondroitin SulfatesDermatan SulfateFibronectinsIduronic AcidRacemases and EpimerasesXenopus ProteinsCancerCell migrationDermatan sulfateMusculocontractural Ehlers–Danlos syndromeNeural crestXenopus

Identifiers

PMID27101845
PMCPMC4920151
OpenAlexW2340045256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.